Combined treatment of prednisolone and angiotensin II receptor blocker in IgA nephropathy.

被引：0
|
作者：
Ihm, CG
Lee, SH
Lee, SH
Kim, YH
Lee, T
Kim, MJ
机构：
[1] Kyung Hee Univ, Coll Med, Seoul, South Korea
[2] InJe Univ, Coll Med, Seoul, South Korea
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2003年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：752A / 752A
页数：1
相关论文
共 50 条
  • [1] ALDOSTERONE BREAKTHROUGH DURING COMBINED ANGIOTENSIN-CONVERTING ENZYME INHIBITOR AND ANGIOTENSIN II RECEPTOR BLOCKER IN PATIENTS WITH IGA NEPHROPATHY
    Horita, Yoshio
    Tadokoro, Masato
    Taura, Kouichi
    Taguchi, Takashi
    Miyazaki, Masanobu
    Kohno, Shigeru
    NEPHROLOGY, 2005, 10 : A37 - A37
  • [2] Optimal dose for renoprotection by the angiotensin II receptor blocker candesartan in patients with type 2 diabetes and nephropathy.
    Rossing, K
    Christensen, PK
    Jacobsen, PK
    Hansen, BV
    Parving, HH
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 653A - 653A
  • [3] Re-biopsy in a patient with IgA nephropathy showing success of treatment with cyclosporin A and angiotensin-II receptor blocker
    Machiguchi T.
    Tei M.
    Ono T.
    Kambara H.
    Clinical and Experimental Nephrology, 2002, 6 (3) : 166 - 169
  • [4] Sparsentan Dual angiotensin II AT1 receptor blocker and endothelin ETA receptor antagonist Treatment of focal segmental glomerulosclerosis Treatment of IgA nephropathy
    Trachtman, H.
    Hogan, J. J.
    Tesar, V
    Komers, R.
    DRUGS OF THE FUTURE, 2020, 45 (02) : 79 - 98
  • [5] Angiotensin receptor blockers in diabetic nephropathy.
    Price D.A.
    Hollenberg N.K.
    Current Diabetes Reports, 2001, 1 (3) : 267 - 274
  • [6] Renoprotective effects of adding angiotensin II receptor blocker to maximal recommended doses of ACE-inhibitor in diabetic nephropathy.
    Rossing, K
    Jacobsen, PK
    Pietraszek, L
    Parving, HH
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 601A - 601A
  • [7] Long-term trial of steroid and angiotensin receptor blocker in IgA nephropathy
    Ihm, Chun-Gyoo
    Lee, T.
    Lee, S.
    Jeong, K.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 62 - 62
  • [8] Combination use of angiotensin II receptor blocker and ace inhibitor in the treatment of diabetic nephropathy
    Mark E. Molitch
    Current Diabetes Reports, 2002, 2 (6) : 521 - 522
  • [9] Intrarenal angiotensin II plays an important role in renal fibrosis in primary IgA nephropathy.
    Han Wen-lun
    Zhu Yun-yun
    Zhong Yu
    Ding Hui-deng
    BIOMEDICAL RESEARCH-INDIA, 2016, 27 (02): : 318 - 321
  • [10] Angiotensin II type 1 receptor blocker combined with hydrochlorothiazide for the treatment of hypertension
    Miura, Shin-ichiro
    Saku, Keijiro
    INTERNAL MEDICINE, 2008, 47 (13) : 1163 - 1164
12345